Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(5):389–98.
Article
Google Scholar
Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore, MD). 2016;64(1):73–84.
Article
Google Scholar
Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology (Baltimore, MD). 1990;12(5):1106–10.
Article
CAS
Google Scholar
Caussy C, Alquiraish MH, Nguyen P, Hernandez C, Cepin S, Fortney LE, Ajmera V, Bettencourt R, Collier S, Hooker J, et al. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology (Baltimore, MD). 2018;67(4):1348–59.
Article
CAS
Google Scholar
Weaver L, Hamoud AR, Stec DE, Hinds TD Jr. Biliverdin reductase and bilirubin in hepatic disease. Am J Physiol Gastrointest Liver Physiol. 2018;314(6):G668–76.
Article
CAS
Google Scholar
Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA. 2002;99(25):16093–8.
Article
CAS
Google Scholar
Ritter JK, Kessler FK, Thompson MT, Grove AD, Auyeung DJ, Fisher RA. Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: evidence for both genetic and environmental influences. Hepatology (Baltimore, MD). 1999;30(2):476–84.
Article
CAS
Google Scholar
Hamoud AR, Weaver L, Stec DE, Hinds TD Jr. Bilirubin in the Liver-Gut Signaling Axis. Trends Endocrinol Metab. 2018;29(3):140–50.
Article
CAS
Google Scholar
Chang Y, Ryu S, Zhang Y, Son HJ, Kim JY, Cho J, Guallar E. A cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workers. PLoS ONE. 2012;7(5):e37241.
Article
CAS
Google Scholar
Puri K, Nobili V, Melville K, Corte CD, Sartorelli MR, Lopez R, Feldstein AE, Alkhouri N. Serum bilirubin level is inversely associated with nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2013;57(1):114–8.
Article
CAS
Google Scholar
Tian J, Zhong R, Liu C, Tang Y, Gong J, Chang J, Lou J, Ke J, Li J, Zhang Y, et al. Association between bilirubin and risk of Non-Alcoholic Fatty Liver Disease based on a prospective cohort study. Sci Rep. 2016;6:31006.
Article
CAS
Google Scholar
Kunutsor SK, Frysz M, Verweij N, Kieneker LM, Bakker SJL, Dullaart RPF. Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study. Eur J Epidemiol. 2020;35(2):123–37.
Article
CAS
Google Scholar
Luo L, An P, Jia X, Yue X, Zheng S, Liu S, Chen Y, An W, Winkler CA, Duan Z. Genetically regulated bilirubin and risk of non-alcoholic fatty liver disease: a Mendelian Randomization Study. Front Genet. 2018;9:662.
Article
CAS
Google Scholar
Lin YC, Chang PF, Hu FC, Chang MH, Ni YH. Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease. Pediatrics. 2009;124(6):e1221-1227.
Article
Google Scholar
Zhang Q, Zhu Y, Yu W, Xu Z, Zhao Z, Liu S, Xin Y, Lv K. Diagnostic accuracy assessment of molecular prediction model for the risk of NAFLD based on MRI-PDFF diagnosed Chinese Han population. BMC Gastroenterol. 2021;21(1):88.
Article
Google Scholar
Middleton MS, Heba ER, Hooker CA, Bashir MR, Fowler KJ, Sandrasegaran K, Brunt EM, Kleiner DE, Doo E, Van Natta ML, et al. Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology. 2017;153(3):753–61.
Article
Google Scholar
Xiong Q, Shuai W, Zhou CL, Dong W. Circulating bilirubin level is determined by both erythrocyte amounts and the proportion of aged erythrocytes in ageing and cardiovascular diseases. Biomed Pharmacother. 2020;123:109744.
Article
CAS
Google Scholar
Zhang X, Meng Z, Li X, Liu M, Ren X, Zhu M, He Q, Zhang Q, Song K, Jia Q, et al. The association between total bilirubin and serum triglyceride in both sexes in Chinese. Lipids Health Dis. 2018;17(1):217.
Article
CAS
Google Scholar
Du Toit WL, Schutte AE, Mels CMC. The relationship of blood pressure with uric acid and bilirubin in young lean and overweight/obese men and women: the African-PREDICT study. J Hum Hypertens. 2020;34(9):648–56.
Article
Google Scholar
Hjelkrem M, Morales A, Williams CD, Harrison SA. Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH). Aliment Pharmacol Ther. 2012;35(12):1416–23.
Article
CAS
Google Scholar
Mishler JMT, Barbosa L, Mihalko LJ, McCarter H. Serum bile acids and alanine aminotransferase concentrations. Comparison of efficacy as indirect means of identifying carriers of non-A, non-B hepatitis agents and of onset, severity, and duration of posttransfusion non-A, non-B hepatitis in recipients. JAMA. 1981;246(20):2340–4.
Article
Google Scholar
Kumar R, Rastogi A, Maras JS, Sarin SK. Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: a favorable endogenous response. Clin Biochem. 2012;45(3):272–4.
Article
CAS
Google Scholar
Salomone F, Li Volti G, Rosso C, Grosso G, Bugianesi E. Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis. J Gastroenterol Hepatol. 2013;28(7):1202–8.
Article
CAS
Google Scholar
Ritter JK. Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chem Biol Interact. 2000;129(1–2):171–93.
Article
CAS
Google Scholar
Bock KW. Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels. Biochem Pharmacol. 2010;80(6):771–7.
Article
CAS
Google Scholar
Meech R, Hu DG, McKinnon RA, Mubarokah SN, Haines AZ, Nair PC, Rowland A, Mackenzie PI. The UDP-glycosyltransferase (UGT) superfamily: new members, new functions, and novel paradigms. Physiol Rev. 2019;99(2):1153–222.
Article
CAS
Google Scholar
Koide CL, Collier AC, Berry MJ, Panee J. The effect of bamboo extract on hepatic biotransforming enzymes–findings from an obese-diabetic mouse model. J Ethnopharmacol. 2011;133(1):37–45.
Article
Google Scholar
Serra A, Bryant N, Motilva MJ, Blumberg JB, Chen CY. Fetal programming of dietary fructose and saturated fat on hepatic quercetin glucuronidation in rats. Nutrition (Burbank, Los Angeles County, Calif). 2012;28(11–12):1165–71.
Article
CAS
Google Scholar
Hardwick RN, Ferreira DW, More VR, Lake AD, Lu Z, Manautou JE, Slitt AL, Cherrington NJ. Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease. Drug Metab Dispos Biol Fate Chem. 2013;41(3):554–61.
Article
CAS
Google Scholar